Low levels of a protein that helps to regulate B-cell activity may explain why these immune cells turn highly active,…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
The use of Enjaymo (sutimlimab) was seen to prevent symptoms of cold agglutinin disease (CAD) from worsening in…
Twice-daily dosing of ANX1502, Annexon Biosciences’ experimental oral therapy for autoimmune conditions such as cold agglutinin disease (CAD),…
For a man in Japan, cold agglutinin disease (CAD) was complicated by pulmonary thrombosis, which occurs when a blood…
About one in five people infected with the virus that causes COVID-19 test positive on a direct Coombs test,…
A young woman in Colombia developed cold agglutinin disease (CAD) secondary to systemic lupus erythematosus (SLE), an autoimmune disease…
A man with cold agglutinin disease (CAD) had significant red blood cell clumping in his coronary arteries during a…
For a toddler in Brazil, cold agglutinin disease (CAD) occurred secondary to an infection with an adenovirus, a common…
Legionnaires’ disease — a lung infection caused by a group of bacteria called Legionella — caused secondary cold agglutinin…
A young woman developed cold agglutinin disease (CAD) secondary to pneumonia, but responded well to red blood cell…